Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. Bitte wende dich an die englische Version für einen Quelltext.

Functional Massage Versus Passive Mobilization After Total Knee Replacement

3. November 2026 aktualisiert von: Azienda Ospedaliera Universitaria Integrata Verona

Functional Recovery in the Acute Phase After Total Knee Arthroplasty: A Randomized Controlled Trial Comparing Two Different Physiotherapy Protocols

This study compares two physiotherapy treatments to help adults recover movement after total knee replacement: functional massage and passive knee mobilization. The main question is whether functional massage helps patients bend their knee further by the time they leave the acute hospital ward.

Forty adults undergoing replacement of one knee or both knees during the same operation will be randomly assigned to one of two groups. One group will receive functional massage according to Olaf Evjenth, and the other will receive passive manual knee mobilization. Both groups will also receive the same standard rehabilitation and pain management.

The assigned treatment will be provided once daily, starting on the first day after surgery and continuing until hospital discharge. Each treatment will last 10 minutes per operated knee.

A clinician who does not know which treatment the patient received will assess knee movement. The study will also evaluate pain, functional mobility, patient-reported outcomes, and length of hospital stay.

Studienübersicht

Status

Noch keine Rekrutierung

Bedingungen

Intervention / Behandlung

Detaillierte Beschreibung

This is a single-center, randomized, parallel-group superiority trial comparing two manual physiotherapy approaches during the acute phase after total knee arthroplasty.

An independent researcher will generate the random allocation sequence. Allocation will be concealed using sequentially numbered, opaque, sealed envelopes, opened after eligibility has been confirmed and written informed consent obtained.

The primary analysis will follow the intention-to-treat principle. Passive knee flexion at discharge will be compared between groups using analysis of covariance, with baseline knee flexion as a covariate. For participants undergoing simultaneous bilateral total knee arthroplasty, one knee will be randomly selected for the primary analysis. A sensitivity analysis using mixed-effects models will account for paired knee measurements. Exploratory analyses will compare treatment effects in participants undergoing unilateral and simultaneous bilateral surgery.

Discharge timing depends on the availability of a bed in an inpatient rehabilitation facility rather than on predefined functional recovery thresholds.

Studientyp

Interventionell

Einschreibung (Geschätzt)

40

Phase

  • Unzutreffend

Kontakte und Standorte

Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.

Studienkontakt

Studienorte

    • Verona
      • Verona, Verona, Italien, 37126
        • Azienda Ospedaliera Universitaria Integrata Verona - U.O.C. Ortopedia, Ospedale Chirurgico Confortini
        • Kontakt:
        • Kontakt:
        • Hauptermittler:
          • Simone Patuzzo

Teilnahmekriterien

Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.

Zulassungskriterien

Studienberechtigtes Alter

18 Jahre bis 79 Jahre (Erwachsene, Älterer Erwachsener)

Akzeptiert gesunde Freiwillige

Nein

Studienberechtigte Geschlechter

Alle

Beschreibung

Inclusion Criteria:

  • Male and female patients aged 18 to 79 years.
  • Scheduled for elective primary total knee arthroplasty, either unilateral or simultaneous bilateral.
  • Ability to understand the nature of the study and provide written informed consent.

Exclusion Criteria:

  • Revision total knee arthroplasty.
  • Age 80 years or older.
  • Severe comorbidities that could interfere with participation in the rehabilitation protocol or outcome assessment, including severe heart failure, severe chronic obstructive pulmonary disease, severe obesity with body mass index greater than 40 kg/m², or neurological conditions with significant motor deficits.
  • Cognitive deficits that prevent understanding and signing the informed consent or active participation in rehabilitation.
  • Total knee arthroplasty performed for non-degenerative causes, such as acute trauma or tumors.
  • Concomitant participation in another interventional clinical trial.

Studienplan

Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.

Wie ist die Studie aufgebaut?

Designdetails

  • Hauptzweck: Behandlung
  • Zuteilung: Zufällig
  • Interventionsmodell: Parallele Zuordnung
  • Maskierung: Single

Waffen und Interventionen

Teilnehmergruppe / Arm
Intervention / Behandlung
Experimental: Functional Massage

Participants receive functional massage according to Olaf Evjenth once daily from postoperative day 1 until hospital discharge, together with standardized pain management, assisted walking, and strengthening exercises.

Functional massage of the anterior thigh with passive or active-assisted knee flexion, performed with the patient seated. Treatment lasts 10 minutes per operated knee, once daily, from postoperative day 1 until hospital discharge.

Aktiver Komparator: Passive Manual Mobilization

Participants receive passive manual knee mobilization once daily from postoperative day 1 until hospital discharge, together with standardized pain management, assisted walking, and strengthening exercises.

Passive manual knee flexion and extension in the sagittal plane, performed with the patient supine. Treatment lasts 10 minutes per operated knee, once daily, from postoperative day 1 until hospital discharge.

Was misst die Studie?

Primäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Knee Flexion
Zeitfenster: Daily from postoperative day 1 until hospital discharge, typically 5-7 days after surgery.

Passive knee flexion is measured in degrees using a standard goniometer, with the assessor moving the knee. Measurements are collected daily from postoperative day 1 until hospital discharge

Daily from postoperative day 1 until hospital discharge, typically 5-7 days after surgery.

Sekundäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Pain Intensity
Zeitfenster: At baseline and daily from postoperative day 1 until hospital discharge, typically 5-7 days after surgery.

Pain intensity is assessed using a Visual Analogue Scale and recorded on a 0-10 scale, with higher scores indicating greater pain. Measurements are collected at baseline and daily after each rehabilitation session from postoperative day 1 until hospital discharge, including the discharge day. Each daily measurement is recorded separately.

At baseline and daily from postoperative day 1 until hospital discharge, typically 5-7 days after surgery.
Timed Up and Go Test
Zeitfenster: Daily from postoperative day 1 until hospital discharge, typically 5-7 days after surgery.

Time in seconds required to stand up, walk 3 meters, turn, walk back, and sit down. The test is performed daily after the rehabilitation session from postoperative day 1 until hospital discharge, including the discharge day. Shorter times indicate better functional mobility. Each daily measurement is recorded separately.

Daily from postoperative day 1 until hospital discharge, typically 5-7 days after surgery.
Length of Hospital Stay
Zeitfenster: At discharge from the acute hospital ward, typically 5-7 days after surgery.

Number of days from admission to the acute hospital ward until discharge

At discharge from the acute hospital ward, typically 5-7 days after surgery.
Oxford Knee Score on Postoperative Day 1
Zeitfenster: Postoperative day 1.

The Oxford Knee Score is a 12-item questionnaire assessing knee pain and difficulties with everyday activities over the previous four weeks. Each item is scored from 0 to 4. The total score ranges from 0 to 48, with higher scores indicating less pain and better function.

Postoperative day 1.
Oxford Knee Score at Hospital Discharge
Zeitfenster: At discharge from the acute hospital ward, typically 5-7 days after surgery.

The Oxford Knee Score is a 12-item questionnaire assessing knee pain and difficulties with everyday activities over the previous four weeks. Each item is scored from 0 to 4. The total score ranges from 0 to 48, with higher scores indicating less pain and better function.

At discharge from the acute hospital ward, typically 5-7 days after surgery.
Oxford Knee Score at 1 Month
Zeitfenster: 1 month after surgery

The Oxford Knee Score is a 12-item questionnaire assessing knee pain and difficulties with everyday activities over the previous four weeks. Each item is scored from 0 to 4. The total score ranges from 0 to 48, with higher scores indicating less pain and better function. The questionnaire is administered by telephone interview.

1 month after surgery
Oxford Knee Score at 3 Months
Zeitfenster: 3 months after surgery

The Oxford Knee Score is a 12-item questionnaire assessing knee pain and difficulties with everyday activities over the previous four weeks. Each item is scored from 0 to 4. The total score ranges from 0 to 48, with higher scores indicating less pain and better function. The questionnaire is administered by telephone interview.

3 months after surgery
EQ-5D-5L Utility Index at day 1
Zeitfenster: Postoperative day 1.

The EQ-5D-5L assesses five dimensions of health: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each dimension has five response levels, from no problems to extreme problems or inability to perform the activity. Responses are converted into a health utility index using a country-specific value set. Higher index values indicate better health-related quality of life

Postoperative day 1.
EQ-5D-5L Utility Index at discharge
Zeitfenster: At discharge from the acute hospital ward, typically 5-7 days after surgery.

The EQ-5D-5L assesses five dimensions of health: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each dimension has five response levels, from no problems to extreme problems or inability to perform the activity. Responses are converted into a health utility index using a country-specific value set. Higher index values indicate better health-related quality of life.

At discharge from the acute hospital ward, typically 5-7 days after surgery.
EQ-5D-5L Utility Index at 1 Month
Zeitfenster: 1 month after surgery

The EQ-5D-5L assesses five dimensions of health: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each dimension has five response levels, from no problems to extreme problems or inability to perform the activity. Responses are converted into a health utility index using a country-specific value set. Higher index values indicate better health-related quality of life. The questionnaire is administered by telephone

1 month after surgery
EQ-5D-5L Utility Index at 3 Months
Zeitfenster: 3 months after surgery

The EQ-5D-5L assesses five dimensions of health: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each dimension has five response levels, from no problems to extreme problems or inability to perform the activity. Responses are converted into a health utility index using a country-specific value set. Higher index values indicate better health-related quality of life. The questionnaire is administered by telephone

3 months after surgery
EQ VAS on Postoperative Day 1
Zeitfenster: On postoperative day 1.

Participants rate their overall health today on a scale from 0 (the worst health they can imagine) to 100 (the best health they can imagine). Higher scores indicate better self-rated health.

On postoperative day 1.
EQ VAS at Hospital Discharge
Zeitfenster: At hospital discharge, typically 5-7 days after surgery.

Participants rate their overall health today on a scale from 0 (the worst health they can imagine) to 100 (the best health they can imagine). Higher scores indicate better self-rated health.

At hospital discharge, typically 5-7 days after surgery.
EQ VAS at 1 Month
Zeitfenster: At 1 month after surgery.

Participants rate their overall health today on a scale from 0 (the worst health they can imagine) to 100 (the best health they can imagine). Higher scores indicate better self-rated health.The assessment is administered by telephone

At 1 month after surgery.
EQ VAS at 3 Months
Zeitfenster: At 3 months after surgery.

Participants rate their overall health today on a scale from 0 (the worst health they can imagine) to 100 (the best health they can imagine). Higher scores indicate better self-rated health. The assessment is administered by telephone

At 3 months after surgery.

Andere Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Walking Distance During Assisted Ambulation
Zeitfenster: Daily from postoperative day 1 until hospital discharge, typically 5-7 days after surgery.

Distance walked during assisted ambulation, measured in meters and recorded daily after the rehabilitation session.

Daily from postoperative day 1 until hospital discharge, typically 5-7 days after surgery.

Mitarbeiter und Ermittler

Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.

Sponsor

Ermittler

  • Hauptermittler: Simone Patuzzo, Azienda Ospedaliera Universitaria Integrata Verona

Studienaufzeichnungsdaten

Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.

Haupttermine studieren

Studienbeginn (Geschätzt)

24. November 2026

Primärer Abschluss (Geschätzt)

1. Mai 2028

Studienabschluss (Geschätzt)

1. August 2028

Studienanmeldedaten

Zuerst eingereicht

3. November 2026

Zuerst eingereicht, das die QC-Kriterien erfüllt hat

3. November 2026

Zuerst gepostet (Tatsächlich)

9. November 2026

Studienaufzeichnungsaktualisierungen

Letztes Update gepostet (Tatsächlich)

9. November 2026

Letztes eingereichtes Update, das die QC-Kriterien erfüllt

3. November 2026

Zuletzt verifiziert

1. November 2026

Mehr Informationen

Begriffe im Zusammenhang mit dieser Studie

Andere Studien-ID-Nummern

  • TKA-PATUZZO-2025-01
  • 1000CET (Andere Kennung: Comitato Etico Territoriale Area Sud-Ovest Veneto (CET-ASOV))

Plan für individuelle Teilnehmerdaten (IPD)

Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?

NEIN

Arzneimittel- und Geräteinformationen, Studienunterlagen

Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt

Nein

Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt

Nein

Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .